Immunotherapy for acute myelogenous leukaemia.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002469:Cell Separation; D003596:Cytosine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005500:Follow-Up Studies; D005615:Freezing; D006801:Humans; D007114:Immunization; D007167:Immunotherapy; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents; D003596:Cytosine; D003630:Daunorubicin